Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexate

被引：0
|
作者：
Sang-Won Lee
Hee-Jin Park
Beom Kyung Kim
Kwang-Hyub Han
Soo-Kon Lee
Seung Up Kim
Yong-Beom Park
机构：
[1] Yonsei University College of Medicine,Department of Internal Medicine
[2] Yonsei University College of Medicine,Institute for Immunology and Immunological Diseases
[3] Yonsei University College of Medicine,Department of Medical Sciences
[4] Yonsei University College of Medicine,Institute of Gastroenterology
[5] Yonsei University College of Medicine,Liver Cirrhosis Clinical Research Center
来源：
Arthritis Research & Therapy | / 14卷
关键词：
Rheumatoid Arthritis; Rheumatoid Arthritis Patient; Chronic Liver Disease; Liver Fibrosis; Cumulative Dose;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexate
    Lee, Sang-Won
    Park, Hee-Jin
    Kim, Beom Kyung
    Han, Kwang-Hyub
    Lee, Soo-Kon
    Kim, Seung Up
    Park, Yong-Beom
    ARTHRITIS RESEARCH & THERAPY, 2012, 14 (05)
  • [2] CONCURRENT USE OF METHOTREXATE AND CELECOXIB INCREASES RISK OF SILENT LIVER FIBROSIS IN RHEUMATOID ARTHRITIS PATIENTS WITH REDUCED KIDNEY FUNCTION
    Park, J.
    Park, Y. -B.
    Lee, S. -K.
    Lee, S. -W.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 647 - 647
  • [3] Concurrent use of methotrexate and celecoxib increases risk of silent liver fibrosis in rheumatoid arthritis patients with subclinical reduced kidney function
    Jin Su Park
    Min-Chan Park
    Yong-Beom Park
    Soo-Kon Lee
    Sang-Won Lee
    Clinical Rheumatology, 2014, 33 : 1415 - 1423
  • [4] Concurrent use of methotrexate and celecoxib increases risk of silent liver fibrosis in rheumatoid arthritis patients with subclinical reduced kidney function
    Park, Jin Su
    Park, Min-Chan
    Park, Yong-Beom
    Lee, Soo-Kon
    Lee, Sang-Won
    CLINICAL RHEUMATOLOGY, 2014, 33 (10) : 1415 - 1423
  • [5] Liver Fibrosis in Rheumatoid Arthritis Patients Treated with Methotrexate
    Hilal, Ghizlane
    Akasbi, Nessrine
    Boudouaya, Hanae
    Salma, Ksir
    Harzy, Taoufik
    CURRENT RHEUMATOLOGY REVIEWS, 2020, 16 (04) : 293 - 297
  • [6] CHARACTERISITCS OF PATIENTS RECEIVING LEFLUNOMIDE, METHOTREXATE OR LEFLUNOMIDE PLUS METHOTREXATE FOR THE TREATMENT OF RHEUMATOID ARTHRITIS IN A REAL-LIFE SETTING IN COLOMBIA
    Santos-Moreno, R.
    Villarreal Peralta, L.
    Jaimes, H.
    Jaimes, J.
    Buitrago-Garcia, D.
    Castro, C.
    VALUE IN HEALTH, 2017, 20 (09) : A941 - A941
  • [7] Liver toxicity is rare in rheumatoid arthritis patients using combination therapy with leflunomide and methotrexate
    Nunes Rodrigues Alves, Jorge Augusto
    de Magalhaes Souza Fialho, Sonia Cristina
    Morato, Edelton Flavio
    de Castro, Glaucio RicardoWerner
    Zimmermann, Adriana Fontes
    Ribeiro, Giovana Gomes
    Neves, Fabricio Souza
    Pereira, Ivanio Alves
    REVISTA BRASILEIRA DE REUMATOLOGIA, 2011, 51 (02) : 138 - 144
  • [8] Leflunomide or methotrexate for juvenile rheumatoid arthritis
    Silverman, E
    Mouy, R
    Spiegel, L
    Jung, LK
    Saurenmann, RK
    Lahdenne, P
    Horneff, G
    Calvo, I
    Szer, IS
    Simpson, K
    Stewart, JA
    Strand, V
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (16): : 1655 - 1666
  • [9] Methotrexate use and liver outcomes in psoriasis and rheumatoid arthritis patients: A commentary on "Risk of liver disease in patients with psoriasis, psoriatic arthritis and rheumatoid arthritis receiving methotrexate: A population-based study''
    Gau, Shuo-Yan
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (06) : E399 - E400
  • [10] LIVER-BIOPSY IN PATIENTS WITH RHEUMATOID-ARTHRITIS RECEIVING METHOTREXATE
    RUBINSTEIN, H
    KLAMUT, M
    ADAMS, E
    SUNDSTROM, W
    CLINICAL RESEARCH, 1985, 33 (04): : A922 - A922
12345